SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640455-21-000055
Filing Date
2021-02-25
Accepted
2021-02-25 14:39:02
Documents
86
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jnce-20201231.htm   iXBRL 10-K 1873922
2 EX-10.5 jnce12312020exhibit105.htm EX-10.5 15825
3 EX-21.1 jnce12312020exhibit211.htm EX-21.1 5321
4 EX-23.1 jnce12312020exhibit231.htm EX-23.1 4177
5 EX-31.1 jnce12312020exhibit311.htm EX-31.1 8887
6 EX-31.2 jnce12312020exhibit312.htm EX-31.2 8895
7 EX-32.1 jnce12312020exhibit321.htm EX-32.1 7287
13 jnce-20201231_g1.jpg GRAPHIC 126782
  Complete submission text file 0001640455-21-000055.txt   8282384

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20201231.xsd EX-101.SCH 47262
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20201231_cal.xml EX-101.CAL 92511
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20201231_def.xml EX-101.DEF 289823
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20201231_lab.xml EX-101.LAB 660991
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20201231_pre.xml EX-101.PRE 443602
14 EXTRACTED XBRL INSTANCE DOCUMENT jnce-20201231_htm.xml XML 1219358
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37998 | Film No.: 21679522
SIC: 2836 Biological Products, (No Diagnostic Substances)